LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 50.36 | 84.90 | 2370 | 5651 | 0.4194 | 0.7327 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 52.06 | 84.90 | 220 | 5990 | 0.0367 | 0.1677 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 52.06 | 84.90 | 2351 | 5990 | 0.3924 | 0.7174 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 52.06 | 84.90 | 2383 | 5990 | 0.3978 | 0.7212 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 52.06 | 84.90 | 2449 | 5990 | 0.4088 | 0.7289 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 53.77 | 84.90 | 267 | 6252 | 0.0427 | 0.2029 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 53.77 | 84.90 | 2440 | 6252 | 0.3902 | 0.7185 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 53.77 | 84.90 | 2490 | 6252 | 0.3982 | 0.7241 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 53.77 | 84.90 | 2555 | 6252 | 0.4086 | 0.7313 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 55.48 | 84.90 | 257 | 6567 | 0.0391 | 0.1931 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 55.48 | 84.90 | 2536 | 6567 | 0.3861 | 0.7185 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 55.48 | 84.90 | 2604 | 6567 | 0.3965 | 0.7258 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 55.48 | 84.90 | 2660 | 6567 | 0.4050 | 0.7317 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 57.18 | 84.90 | 261 | 6963 | 0.0375 | 0.1932 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 57.18 | 84.90 | 2640 | 6963 | 0.3791 | 0.7170 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 57.18 | 84.90 | 2702 | 6963 | 0.3880 | 0.7233 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 57.18 | 84.90 | 2773 | 6963 | 0.3982 | 0.7304 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 58.88 | 84.90 | 267 | 7291 | 0.0366 | 0.1953 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 58.88 | 84.90 | 2693 | 7291 | 0.3693 | 0.7127 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 58.88 | 84.90 | 2814 | 7291 | 0.3859 | 0.7245 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 58.88 | 84.90 | 2892 | 7291 | 0.3966 | 0.7319 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 60.59 | 84.90 | 272 | 7641 | 0.0356 | 0.1964 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 60.59 | 84.90 | 2841 | 7641 | 0.3718 | 0.7173 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 60.59 | 84.90 | 2902 | 7641 | 0.3797 | 0.7229 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 60.59 | 84.90 | 2980 | 7641 | 0.3900 | 0.7299 | MN20160318_Q02 | F04 |